D68.31Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

D68.31 is the ICD-10-CM diagnosis code for hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors. It belongs to category D68 (other coagulation defects), block D65-D69 (coagulation defects, purpura and other hemorrhagic conditions) and chapter 3 (diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism). It is a header code, so it can't be reported by itself; one of its 3 subcodes must be used instead.

Within D68.3 (hemorrhagic disorder due to circulating anticoagulants), D68.31 is specifically for hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors. Related codes cover extrinsic circulating anticoagulants (D68.32).

To report this condition, pick the subcode that matches the documentation: D68.311 (hemophilia), D68.312 (disorder) and D68.318 (inhibitors).

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.